TG THERAPEUTICS, INC. - COM (TGTX)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
101M
Holdings value Q3 2024
$2.36B
Value change Q3 2024
-$25.5M
Grand Portfolio weight change Q3 2024
0%
Number of holders
297
Number of buys Q3 2024
181
Number of sells Q3 2024
-112
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 101M $2.36B -$25.5M $23.39 300
2024 Q2 93.1M $1.66B +$72.1M $17.79 250
2024 Q1 89.4M $1.36B -$29.6M $15.21 233
2023 Q4 90.3M $1.54B +$77.5M $17.08 232
2023 Q3 89.6M $748M -$292M $8.36 230
2023 Q2 88.2M $2.19B -$89M $24.84 247
2023 Q1 94.7M $1.42B +$49.9M $15.04 212
2022 Q4 93.3M $1.1B -$26.2M $11.83 196
2022 Q3 98.6M $584M -$40M $5.92 171
2022 Q2 106M $452M -$5.02M $4.25 163
2022 Q1 101M $959M -$98M $9.51 174
2021 Q4 100M $1.9B +$38.9M $19.00 190
2021 Q3 96.3M $3.2B -$38.6M $33.28 216
2021 Q2 96M $3.73B -$125M $38.79 236
2021 Q1 98.8M $4.77B -$16.6M $48.20 235
2020 Q4 99.9M $5.2B +$670M $52.02 251
2020 Q3 87.7M $2.35B +$119M $26.76 181
2020 Q2 83.9M $1.63B +$391M $19.48 175
2020 Q1 64.8M $639M +$63.4M $9.84 143
2019 Q4 58.2M $646M +$108M $11.10 136
2019 Q3 48.4M $272M -$14.8M $5.62 115
2019 Q2 50.2M $434M +$21.8M $8.65 117
2019 Q1 48.1M $387M +$29.4M $8.04 111
2018 Q4 48.9M $200M -$48.5K $4.10 108
2018 Q3 47.7M $267M +$32M $5.60 124
2018 Q2 40.6M $534M +$25.3M $13.15 126
2018 Q1 38.6M $548M +$48.8M $14.20 120
2017 Q4 35.8M $293M -$8.67M $8.20 104
2017 Q3 35.6M $422M +$16.2M $11.85 96
2017 Q2 34.3M $345M +$34.1M $10.05 103
2017 Q1 30.8M $359M +$141M $11.65 94
2016 Q4 21.7M $101M -$33.5M $4.65 85
2016 Q3 27M $209M -$14.3M $7.74 73
2016 Q2 29.1M $178M -$6.28M $6.06 84
2016 Q1 29.6M $252M +$21.7M $8.52 79
2015 Q4 26.9M $321M -$10.4M $11.93 86
2015 Q3 28M $283M +$33M $10.08 81
2015 Q2 23.9M $396M +$21.7M $16.59 89
2015 Q1 21.4M $332M +$42.2M $15.48 78
2014 Q4 18.7M $295M +$46.7M $15.84 76
2014 Q3 15.5M $165M +$27.3M $10.67 65
2014 Q2 13M $122M +$12.3M $9.39 64
2014 Q1 11.6M $80.3M +$31.8M $6.90 49